| Cancer Information Highlights |
| From the National Cancer Institute |
| Updating you about cancer causes, prevention, screening, treatment, coping, and more |
| |
| New from NCI |
| Program Helps People Being Screened for Lung Cancer Quit Smoking |
 |
|
Results from a large NCI-funded clinical trial show that a program that combines intensive counseling and medications may be an effective way to help smokers being screened for lung cancer quit.
Read More
|
| TACE Plus Drug Combination Effective in Liver Cancer |
 |
|
Treatment for a certain type of liver cancer is likely to change, based on updated findings from two large clinical trials. Both trials tested a procedure called TACE combined with immunotherapy and drugs that block blood flow to tumors.
Read More
|
| Combination Therapy for Metastatic Prostate Cancer Helps Some Men Live Longer |
 |
|
For men with castration-resistant prostate cancer that has spread, initial treatment with enzalutamide (Xtandi) combined with talazoparib (Talzenna) may help them live longer than getting enzalutamide alone, according to updated results from a large clinical trial.
Read More
|
| Advances in Kidney Cancer Research |
 |
|
Read about recent research results and progress in the early detection and treatment of kidney cancer, including studies on targeted therapies and immunotherapies. Selected NCI-supported programs that address kidney cancer are also described.
Read More
|
Video: Engaging More Men in Cancer Prevention Research
Men are often less likely to take part in research studies such as the Connect for Cancer Prevention Study. Learn more about Connect, what’s involved in taking part, and why it’s important.
Watch the Video
|
Childhood Craniopharyngioma
Craniopharyngioma is a rare, benign brain tumor that can press on the pituitary gland as it grows. Although it’s not cancer, it can affect many brain functions, including hormone production, growth, and vision. Learn more about this tumor and its treatment on our recently updated page.
Read More
|
|
| |
|
|
|
|
|
|
